全球血液和血液成分市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

全球血液和血液成分市场需求预计将从 2023 年的 179.6 亿美元达到近 254 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 3.93%。

血液和血液成分是指用于医疗治疗的全血及其分离成分，例如红血球、白血球、血小板和血浆。这些成分对于各种治疗目的至关重要，包括贫血、凝血障碍、创伤和外科手术患者的输血。血液成分与接受者的血型仔细匹配，以确保相容性和安全性。将血液分离成其成分可以进行有针对性的治疗，优化捐献血液的使用并改善各种临床环境中的患者治疗效果。

市场动态

创伤病例、外科手术和慢性疾病的发生率不断上升，需要使用血液和血液成分来有效管理患者的病情。此外，全球人口老化，更容易受到需要输血的医疗状况的影响，显着提振了市场。血液采集、处理和储存技术的进步正在提高血液和血液成分的安全性和效率，进一步推动其需求。人们对捐血的认识不断提高以及政府鼓励自愿捐血的倡议也是推动市场的重要因素。此外，开发先进的筛检和测试方法以确保血液和血液成分的安全也有助于市场成长。全球医院、血库和医疗机构数量的增加正在扩大这些关键产品的可用性和可近性。然而，输血传播感染的风险以及血液处理和储存的高成本可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球血液和血液成分市场的每个细分市场进行了包容性评估。血液和血液成分产业的成长和趋势为本研究提供了整体方法。

市场区隔

血液和血液成分市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

• 全血
• 血液成分（红血球、血小板、血浆、白血球）

按申请

• 贫血
• 创伤与手术
• 癌症治疗
• 出血性疾病
• 其他的

按最终用途

• 医院
• 门诊手术中心
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的血液和血液成分市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。血液和血液成分市场的主要参与者包括欧洲血液联盟、澳洲红十字会、印度红十字会、美国血库协会、南非国家血液服务中心。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：血液和血液成分 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球血液和血液成分市场分析：按产品分类

• 概述（按产品）
• 按产品分类的历史和预测资料分析
• 全血
• 血液成分（红血球、血小板、血浆、白血球）

第 6 章：全球血液与血液成分市场分析：按应用分类

• 概述：按应用
• 历史和预测数据分析：按应用
• 贫血
• 创伤与手术
• 癌症治疗
• 出血性疾病
• 其他的

第 7 章：全球血液与血液成分市场分析：依最终用途分类

• 按最终用途分类的概述
• 按最终用途进行历史和预测资料分析
• 医院
• 门诊手术中心
• 其他的

第 8 章：全球血液和血液成分市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：血液与血液成分公司的竞争格局

• 血液和血液成分市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• European Blood Alliance
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Australian Red Cross
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Indian Red Cross
• 公司简介
• 公司收入
• 产品
• 最近的发展
• American Association Of Blood Banks
• 公司简介
• 公司收入
• 产品
• 最近的发展
• South African National Blood Service
• 公司简介
• 公司收入
• 产品
• 最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

The global demand for Blood and Blood Components Market is presumed to reach the market size of nearly USD 25.4 Billion by 2032 from USD 17.96 Billion in 2023 with a CAGR of 3.93% under the study period 2024-2032.

Blood and blood components refer to whole blood and its separated components, such as red blood cells, white blood cells, platelets, and plasma, used in medical treatments. These components are critical for various therapeutic purposes, including transfusions for patients with anemia, clotting disorders, trauma, and surgical procedures. Blood components are carefully matched to the recipient's blood type to ensure compatibility and safety. The separation of blood into its components allows for targeted treatments, optimizing the use of donated blood and improving patient outcomes in various clinical settings.

MARKET DYNAMICS

The rising incidence of trauma cases, surgical procedures, and chronic diseases necessitates the use of blood and blood components to manage patients' conditions effectively. Additionally, the aging global population, more susceptible to medical conditions requiring blood transfusions, significantly boosts the market. Advancements in blood collection, processing, and storage technologies are enhancing the safety and efficiency of blood and blood components, further driving their demand. The increasing awareness about blood donation and government initiatives to encourage voluntary blood donation are also significant factors propelling the market. Furthermore, the development of advanced screening and testing methods to ensure the safety of blood and blood components contributes to market growth. The rise in the number of hospitals, blood banks, and healthcare facilities globally is expanding the availability and accessibility of these critical products. However, the risk of transfusion-transmitted infections and the high cost of blood processing and storage may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood and Blood Components. The growth and trends of Blood and Blood Components industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood and Blood Components market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Whole Blood
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells)

By Application

• Anaemia
• Trauma & Surgery
• Cancer Treatment
• Bleeding Disorders
• Others

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood and Blood Components market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood and Blood Components market include European Blood Alliance, Australian Red Cross, Indian Red Cross, American Association Of Blood Banks, South African National Blood Service. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BLOOD AND BLOOD COMPONENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Whole Blood Historic and Forecast Sales By Regions
• 5.4. Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Historic and Forecast Sales By Regions

6. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Anaemia Historic and Forecast Sales By Regions
• 6.4. Trauma & Surgery Historic and Forecast Sales By Regions
• 6.5. Cancer Treatment Historic and Forecast Sales By Regions
• 6.6. Bleeding Disorders Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-Use
• 7.2. Historical and Forecast Data Analysis By End-Use
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD AND BLOOD COMPONENTS COMPANIES

• 9.1. Blood and Blood Components Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF BLOOD AND BLOOD COMPONENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. European Blood Alliance
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Australian Red Cross
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Indian Red Cross
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. American Association Of Blood Banks
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. South African National Blood Service
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Blood and Blood Components Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Blood and Blood Components Report
• Market Research Process
• Market Research Methodology
• Global Blood and Blood Components Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-Use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.